Ontology highlight
ABSTRACT:
INSTRUMENT(S): Orbitrap Fusion
ORGANISM(S): Homo Sapiens (human)
TISSUE(S): Anal Canal
DISEASE(S): Anal Canal Squamous Cell Carcinoma
SUBMITTER: Antje Dittmann
LAB HEAD: Jaime Feliu
PROVIDER: PXD037816 | Pride | 2023-04-26
REPOSITORIES: Pride
Action | DRS | |||
---|---|---|---|---|
20220125_002_S346604_11_rep.raw | Raw | |||
20220125_003_S346671_78.raw | Raw | |||
20220125_004_S346624_31.raw | Raw | |||
20220125_005_S346627_34.raw | Raw | |||
20220125_007_S346645_52.raw | Raw |
Items per page: 5 1 - 5 of 85 |
Trilla-Fuertes Lucía L Gámez-Pozo Angelo A Nogué Miguel M Busquier Isabel I Arias Fernando F López-Campos Fernando F Fernández-Montes Ana A Ruiz Ana A Velázquez Concepción C Martín-Bravo Celia C Pérez-Ruiz Elisabeth E Asensio Elena E Hernández-Yagüe Xavier X Rodrigues Aline A Ghanem Ismael I López-Vacas Rocío R Hafez Ahmed A Arias Pedro P Dapía Irene I Solís Mario M Dittmann Antje A Ramos Ricardo R Llorens Carlos C Maurel Joan J Campos-Barros Ángel Á Fresno Vara Juan Ángel JÁ Feliu Jaime J
Cancer 20230425 16
<h4>Background</h4>Anal squamous cell carcinoma (ASCC) is an infrequent tumor whose treatment has not changed since the 1970s. The aim of this study is the identification of biomarkers allowing personalized treatments and improvement of therapeutic outcomes.<h4>Methods</h4>Forty-six paraffin tumor samples from ASCC patients were analyzed by whole-exome sequencing. Copy number variants (CNVs) were identified and their relation to disease-free survival (DFS) was studied and validated in an indepen ...[more]